Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

Clinically evaluated innovation

You strive to provide comprehensive skin and wound care throughout your patients journey from hospital, clinic and home. We are here to support you with innovative, evidence-based products that foster healing and help improve patient outcomes. 

Clinician showing patient how to use the 3M™ ActiV.A.C.™ Therapy System with iOn Progress™ Remote Therapy Monitoring for treatment of VLU. Photo 6

Solutions for every step of the way

Throughout the stages of your patients' wound management needs, Solventum is your partner, offering solutions and leading innovations to navigate the challenges you face. 

Patient in home with 3M™ Coban 2™ Two-Layer Compression System applied to wound. Nurse teaching patient how to use 3M™ ActiV.A.C.™ Therapy Unit.

Negative pressure wound therapy

Each patient and their wounds are distinct, requiring a personalised approach to healing. Solventum's range of negative pressure wound therapy (NPWT) solutions, grounded in science, empower you to transform your wound care practice. These NPWT options have been recognised through clinical studies for their ability to lower care costs and improve patient outcomes.¹⁻³

  • Helps the wound healing process: NPWT fosters an environment conducive to wound healing
  • Exudate management: Helps in managing wound exudate and removal of excess fluids, including infectious materials 
  • Versatility: Effective for various acute and chronic wounds⁴ and adaptable for use in different care settings 
  • Tailored solutions: A broad selection of NPWT systems, from durable devices to compact, portable units and unique wound dressings that provide customised care 

 

Wound characteristics

Acute wounds

Acute wounds, such as burns, lacerations, dehisced wounds, open fractures and amputations, occur suddenly, and change patient’s lives. They can happen to anyone at any time, requiring immediate medical attention and are at risk for further complications. The impact of these wounds can be significant, potentially leading to long-term disability or even life-threatening situations.

  • 5.4% of all emergency department visits are due to traumatic wounds⁵ 
  • V.A.C.® Therapy demonstrated in comparative clinical studies significant acute wound closure in 1/2 the time with early vs late initiation⁶
  • Veraflo™ Therapy aids wound management by instilling and dwelling fluid in the wound bed, accompanied by negative pressure therapy7
Image of an acute wound, surgical stomach clinical image

Closed incisions and preventing SSIs 

Postoperative complications, such as surgical site infections (SSI), can challenge clinicians with consequences that ripple across care settings, including extended hospital stays, disrupted healing, readmissions and reoperation that impact quality metrics, cost of care and patient outcomes. 

The costly reality of at-risk incisions adds to an increasingly complex healthcare environment. Surgeons are facing unique challenges that can negatively affect outcomes. Effectively reducing the risk of surgical site complications or infections is a priority.

Patients with an SSI:

  • Are 6 times more likely to have a 30-day readmission12
  • Have a 7-11 day longer hospital stay on average13
  • Have a 2.2 times longer ICU stay on average12
Step by step application of Tegaderm Absorbent Clear Acrylic Dressing on a knee incision. Dressing shown is 90815 but application would be the same for 90817.

PI prevention and wound management

Pressure injury (PI) prevention and wound management are critical components of patient care, particularly for those with limited mobility or compromised health. They can occur in any setting and have a significant impact on patient comfort, recovery time, and healthcare costs. Effective management involves regular assessments, proactive skin care, and the use of low friction equipment and prophylactic dressings to mitigate risk.14 When treatment is necessary, it's important to accurately identify and classify the injury, establish clear treatment objectives, and implement pain and infection control measures.14

  • 3 - 7 days are added to a patients stay from PIs14
  • 2.5 million people in the U.S. alone develop PIs annually15
  • 60,000 deaths related to pressure injuries annually16
Clinician applying 3M™ Promogran Prisma™ Matrix to sacral pressure ulcer. 3M™ Tegaderm Silicone Foam sacral dressing being applied over top

3M™ V.A.C.® Peel and Place Dressing Kit 

The 3M™ V.A.C.® Peel and Place Dressing is the first 3M™ V.A.C.® Therapy Dressing that can be worn for up to seven days,27* which means you can provide consistent and effective NPWT to your patients with potentially fewer dressing changes, clinic visits and home visits.   

It is designed to:

  • Create an environment that promotes wound healing for your patients   
  • Conform to small wounds up to 2cm, medium wounds up to 4cm and large up to 6cm 
  • Save time with a simple two-minute application process** 
  • In an animal model the authors reported 2.4 times more granulation than with traditional NPWT*
  • Safe to wear up to 7 days

*Information contained within conducted animal studies has not been evaluated in humans. 

**In a simulated use test with 12 nurse and surgeon users. Average time of 01:48. 

3M V.A.C. Peel and Place dressing image, size medium, with liner, front view with the SensaT.R.A.C. Pad.

Contact a Solventum representative

References
  1. Yang CK, Alcantara S, Goss S, Lantis JC 2nd. Cost analysis of negative-pressure wound therapy with instillation for wound bed preparation preceding split-thickness skin grafts for massive (>100 cm(2)) chronic venous leg ulcers. J Vasc Surg. 2015;61(4):995-999. doi:10.1016/j.jvs.2014.11.076 
  2. Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015;27(3):63-72. 
  3. Kwon J, Staley C, McCullough M, et al. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018;68(6):1744-1752. doi:10.1016/j.jvs.2018.05.224 
  4. Willy C, Voelker HU, Englehardt M. Literature on the Subject of Vacuum Therapy: Review and Update. Eur J Trauma Emerg Surg. 2007;33(1):33-39. doi:10.1007/s00068-007-6143-4 
  5. Prevaldi C, et al. Management of traumatic wounds in the Emergency Department: position paper from the Academy of Emergency Medicine and Care (AcEMC) and the World Society of Emergency Surgery (WSES). World J Emerg Surg. 2016;11:30. Published 2016 Jun 18. doi:10.1186/s13017-016-0084-3 
  6. Miller Mikolajczyk C, James RA. Real world use: effect of early versus late initiation of negative pressure wound therapy on wound surface area reduction in patients at wound care clinics. Poster presented at WOCN® Society’s 45th Annual Conference; June 22-26, 2013; Seattle, WA. 
  7. Kim PJ, Lookess S, Bongards C, Griffin LP, Gabriel A. Economic model to estimate cost of negative pressure wound therapy with instillation vs control therapies for hospitalised patients in the United States, Germany, and United Kingdom. Int Wound J. 2022;19(4):888-894. doi:10.1111/iwj.13689 
  8. Brem H, Kirsner RS, Falanga V. Protocol for the successful management of venous ulcers. Am J Surg. 2004;188(1A Suppl):1-8. doi:10.1016/S0002-9610(03)00284-8 
  9. Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals. The hospital management perspective. JAMA Surg. 2013;148(10):907-914. doi:10.1001/jamasurg.2013.2246 
  10. Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist AC, Saiman L, Yokoe DS, Maragakis LL, Kaye KS. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014 Jun;35(6):605-27.
  11. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Quick Reference Guide. Emily Haesler (Ed.). EPUAP/NPIAP/PPPIA: 2019. 
  12. AHRQ National Scorecard on Hospital-Acquired Conditions Updated Baseline Rates and Preliminary Results 2014–2017. Adrq.gov. Published January 2019. Accessed July 5, 2024. https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hacreport-2019.pdf. 
  13. Padula WV, Delarmente BA. The national cost of hospital-acquired pressure injuries in the United States. Int Wound J. 2019;16(3):634-640. doi:10.1111/iwj.13071 
  14. SAT-MTF-05-982101 Evaluation of VAC Peel and Place Dressing Concepts in Full-Thickness Excisional Wounds. 2023. Allen D, Robinson T, Schmidt M, Kieswetter K. Preclinical assessment of novel longer-duration wear negative pressure wound therapy dressing in a porcine model. Wound Rep Reg. 2023;31:349-359.